-J D Morrow Researcher Activity Profile

Research Author Detailed Information 

J D Morrow Publication Rate By Year

J D Morrow has published 1 paper(s) in 1982, 6 paper(s) in 2006, 29 paper(s) in 2007, 2 paper(s) in 2008, for a total of 38 research publications in total.

J D Jd Morrow Author Information

LAST NAME: morrow

FIRST NAME: J D

INITIALS: jd

AFFILIATION:

Papers

J D Morrow's Publication Record

1. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Year Published: 2007
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-6248, USA. ingrid.avalos@vanderbilt.edu
2. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress. Year Published: 2006
Department of Medicine, Vanderbilt University, Nashville, TN 37232-6602, USA. jason.morrow@vanderbilt.edu
3. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Year Published: 2006
Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at University of California at Los Angeles, 90095, USA. kreckamp@mednet.ucla.edu
4. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Year Published: 2006
School of Public Health, University of California, Berkeley, California 94720, USA. gblock@berkeley.edu
5. Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. Year Published: 2006
Department of Biological Sciences and South Carolina Cancer Center, University of South Carolina, Columbia, South Carolina 29203, USA. ddixon@biol.sc.edu
6. In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution. Year Published: 2006
Department of Chemistry, Vanderbilt University, Nashville, TN 37235, USA.
7. Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Year Published: 2006
Department of Surgery, Vanderbilt University, Nashville, Tennessee, USA.
8. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans. Year Published: 2007
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
9. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model. Year Published: 2007
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232, USA. alyssa.hasty@vanderbilt.edu
10. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. Year Published: 2007
Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
11. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Year Published: 2007
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232-6602, USA.
12. Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo. Year Published: 2007
Department of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, USA.
13. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Year Published: 2007
Department of Pediatrics, Division of Reproductive and Development Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2678, USA.
14. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. Year Published: 2007
Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
15. Ibuprofen use during extreme exercise: effects on oxidative stress and PGE2. Year Published: 2007
Department of Health, Leisure, and Exercise Science, Appalachian State University, Boone, NC 28608, USA. mcanltysr@appstate.edu
16. Electrophilic cyclopentenone isoprostanes in neurodegeneration. Year Published: 2007
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, 526 RRB, 23rd and Pierce Aves, Nashville, TN 37232-6602, USA.
17. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. Year Published: 2007
Department of Pathology, University of Washington, Seattle, WA 98104, USA. tmontine@u.washington.edu
18. Influence of carbohydrate, intense exercise, and rest intervals on hormonal and oxidative changes. Year Published: 2007
Dept. of Health, Leisure, and Exercise Science, Appalachian State University, Boone, NC 28608, USA.
19. Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo. Year Published: 2007
Department of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, USA.
20. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Year Published: 2007
Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. jack.roberts@vanderbilt.edu
21. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. Year Published: 2007
Department of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
22. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Year Published: 2007
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
23. In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Year Published: 2007
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
24. Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Year Published: 2007
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. ingrid.avalos@vanderbilt.edu.
25. Effect of pharmacological lowering of plasma urate on exercise-induced oxidative stress. Year Published: 2007
Department of Health, Leisure, and Exercise Science, Appalachian State University, Boone, NC 28608, USA.
26. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Year Published: 2007
Neurovascular Clinical Science Unit, Mater University Hospital and University College Dublin, Ireland. pjkelly@partners.org
27. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. Year Published: 2007
Department of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
28. Influence of carbohydrate, intense exercise, and rest intervals on hormonal and oxidative changes. Year Published: 2007
Dept. of Health, Leisure, and Exercise Science, Appalachian State University, Boone, NC 28608, USA.
29. Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study. Year Published: 2007
Neurovascular Clinical Science Unit, Catherine McAuley Research Center, Mater University Hospital, Nelson St, Dublin 7, Ireland. pjkelly@partners.org.
30. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Year Published: 2007
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
31. In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Year Published: 2007
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
32. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Year Published: 2007
Neurovascular Clinical Science Unit, Mater University Hospital and University College Dublin, Ireland. pjkelly@partners.org
33. Effects of serotonergic activation by 5-hydroxytryptophan on sleep and body temperature of C57BL/6J and interleukin-6-deficient mice are dose and time related. Year Published: 2008
Department of Psychiatry, University of Michigan, Ann Arbor, USA.
34. Effect of pharmacological lowering of plasma urate on exercise-induced oxidative stress. Year Published: 2007
Department of Health, Leisure, and Exercise Science, Appalachian State University, Boone, NC 28608, USA. mcanltysr@appstate.edu
35. Percutaneous transluminal dilatation of the renal artery: follow-up studies on renovascular hypertension. Year Published: 1982
36. Why the United States still needs improved dietary supplement regulation and oversight. Year Published: 2008
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. jason.morrow@vanderbilt.edu
37. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Year Published: 2007
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232-6602, USA.
38. Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Year Published: 2007
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-2681, USA. ingrid.avalos@vanderbilt.edu